PLAT and intracerebral hemorrhage: The Transcranial Ultrasound in Clinical SONothrombolysis trial (TUCSON) showed that a 1.4 mL dose of perflutren-lipid microspheres do not augment further the risk of symptomatic intracerebral hemorrhage, and thus can be safely co-administered during tPA infusion (9, 68).